C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2004
11/17/2004	CN1546682A Process of continuous production of casein bioactive peptide by enzymolysis and filtering membrane concentration
11/17/2004	CN1546671A Recombinant endothelial chalone high expression technology in bacillus coli
11/17/2004	CN1546646A New yeast Pichia strain suitable for high density fermentation
11/17/2004	CN1546172A Hyper-immune serum for resisting SARS virus and its preparation
11/17/2004	CN1175899C Medicine composition and preparation and use thereof
11/16/2004	US6818758 Estrogen receptor beta variants and methods of detection thereof
11/16/2004	US6818750 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
11/16/2004	US6818746 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and skin disorders
11/16/2004	US6818745 For diagnosis/treatment of tumors; drug screening of antitumor agents; metastatic-tumor excreted phosphaturic-element (mepe/phosphatonin)
11/16/2004	US6818628 For inducing in a bovine host an immunological response against bovine respiratory syncytial virus or bovine viral diarrhea virus
11/16/2004	US6818445 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/16/2004	US6818443 Fluorescent proteins
11/16/2004	US6818418 Protein scaffolds for antibody mimics and other binding proteins
11/16/2004	US6818409 Isolation and purification of Clostridium botulinum toxins
11/16/2004	US6818408 Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate
11/16/2004	US6818392 Monoclonal antibodies to human immunodeficiency virus and uses thereof
11/16/2004	US6818259 Remote plasma discharge process is preferably conducted so that no photons, and particularly no ultraviolet radiation, is transmitted from the plasma glow to the porous article
11/16/2004	US6818216 Antibody for use in the treatment of viral infection
11/16/2004	CA2159109C Therapeutic uses of keratinocyte growth factor
11/16/2004	CA2120342C Epstein-barr virus peptides and antibodies against these peptides
11/16/2004	CA2074719C Calcium channel compositions and methods
11/16/2004	CA2059692C Pneumoccoccal polysaccharide conjugate vaccine
11/11/2004	WO2004097530A1 Structure and method for producing structure, toner containing structure, image forming method and device using toner
11/11/2004	WO2004097019A1 Human antihuman interleukin-18 antibody, fragment thereof and method of using the same
11/11/2004	WO2004097018A1 Process for producing recombinant antibody
11/11/2004	WO2004097014A1 High throughput synthesis system and synthesizer for automatically performing the system
11/11/2004	WO2004096999A2 In vitro translation system
11/11/2004	WO2004096992A2 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
11/11/2004	WO2004096978A2 Production of high mannose proteins in plant culture
11/11/2004	WO2004096860A1 Method of producing target protein, fused protein and gene thereof, partial sequence protein of intein and gene thereof, expression vector and transformant
11/11/2004	WO2004096859A1 Chaperonine-target protein complex, method of producing the same, method of stabilizing target protein, method of immobilizing target protein, method of analyzing the structure of target protein, sustained-release preparation and method of producing antibody against target protein
11/11/2004	WO2004096264A1 Method for treating infection with feline leukemia virus
11/11/2004	WO2004096124A2 Compositions and methods for the diagnosis and treatment of tumor
11/11/2004	WO2004084831A3 Optimized expression of hpv 31 l1 in yeast
11/11/2004	WO2004081515A3 Purification process for bacterial cytolysin
11/11/2004	WO2004064750A3 Improved constructs for expressing lysosomal polypeptides
11/11/2004	WO2004032852A3 Methods for treating cardiac arrhythmia and preventing death due to cardiac arrhythmia using ngf antagonists
11/11/2004	WO2004022586A3 Tubulysin biosynthesis gene
11/11/2004	WO2004012681A3 Cancer vaccines containing epitopes of oncofetal antigen
11/11/2004	WO2004009799A3 Ion channel receptor and uses thereof
11/11/2004	WO2004009775A3 Methods and compositions relating to chimeric nicotinic receptor subunits
11/11/2004	WO2003102166A8 Novel flavivirus antigens
11/11/2004	WO2003060150A8 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling
11/11/2004	WO2003046574A3 Complement c3 precursor biopolymer markers indicative of insulin resistance
11/11/2004	WO2003040695A3 Protein knobs
11/11/2004	WO2003038052A3 Nucleic acid-associated proteins
11/11/2004	WO2003027239A3 Melanin-concentrating hormone receptor antagonist binding protein
11/11/2004	WO2003012068A3 Novel fusion proteins and assays for molecular binding
11/11/2004	WO2003012044A3 Hagfish cathelin-associated antimicrobial peptides and genes
11/11/2004	WO2002096350A3 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
11/11/2004	WO2002070665A3 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
11/11/2004	US20040226058 Prolonged culturing of avian (chicken) primordial germ cells (PGCs) using specific growth factors, use thereof to produce chimeric avians (chickens)
11/11/2004	US20040225118 31 human secreted proteins
11/11/2004	US20040225116 Nucleic acid fragments encoding nitrile hydratase and amidase enzymes from comamonas testosteroni 5-MGAM-4D and recombinant organisms expressing those enzymes useful for the production of amides and acids
11/11/2004	US20040224911 Transporters and ion channels
11/11/2004	US20040224910 Recombinant nematode nicotinic receptor and uses
11/11/2004	US20040224393 Modified human granulocyte-colony stimulating factor and process for producing same
11/11/2004	US20040224391 Isolating preferential domain of viral glycoprotein for use in vaccine development; prepare vector, insert furin cleavage sequence between glycoprotein nucleotide sequences, express in cells, expose to protease, recover polypeptide domain, induce immune response
11/11/2004	US20040224388 Hyphal growth in fungi
11/11/2004	US20040224386 Protein tyrosine kinases
11/11/2004	US20040224363 Immunoglobulin for use in diagnosis and prognosis of metastatic breast cancer and degenerative neural conditions; drug screening; immunotherapy and diagnostics; anticarcinogenic agents
11/11/2004	US20040224343 Increasing probabilty of biomolecule associations via exposing/incubating molecules with organic chemicals or bipolar reagents such as ethanol and methanol; intensifying biopolymers stability and reactability
11/11/2004	US20040224314 G-protein coupled receptors
11/11/2004	US20040223976 Influenza virus vaccine
11/11/2004	US20040223968 inhibiting a condition characterized by monocytic infiltrates such as atherosclerosis by administering an MCP-1 receptor antagonist that binds to an MCP-1 receptor polypeptide, especially a humanized or monoclonal antibody.
11/11/2004	US20040223965 Hepatitis b core antigen fusion proteins
11/11/2004	US20040223964 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/11/2004	CA2523912A1 Human antihuman interleukin-18 antibody, fragment thereof and method of using the same
11/11/2004	CA2523539A1 Production of high mannose proteins in plant culture
11/11/2004	CA2523402A1 Group 1 mite polypeptide variants
11/11/2004	CA2523034A1 Method of producing target protein, fused protein and gene thereof, partial sequence protein of intein and gene thereof, expression vector and transformant
11/11/2004	CA2522927A1 High throughput synthesis system and synthesizer for automatically performing the system
11/11/2004	CA2522263A1 Chaperonine-target protein complex, method of producing the same, method of stabilizing target protein, method of immobilizing target protein, method of analyzing the structure oftarget protein, sustained-release preparation and method of producing antibody against target protein
11/11/2004	CA2519241A1 Compositions and methods for the diagnosis and treatment of tumor
11/10/2004	EP1475442A2 Polypeptides of feline T-cell lymphotropic lentivirus
11/10/2004	EP1475440A2 Growth differentiation factor-3
11/10/2004	EP1475436A1 Swine rag-1 gene and utilization thereof
11/10/2004	EP1474682A2 Production of human antibodies in immunodeficient, non-human, mammalian hosts
11/10/2004	EP1474518A2 Method for predicting the expression efficiency in cell-free expression systems
11/10/2004	EP1474515A2 Regulation of human hematopoietin receptor-like protein
11/10/2004	EP1474507A2 Methods and materials for the production of organic products in cells of candida species
11/10/2004	EP1474449A2 Human antibodies for use as a therapeutic agent against vaccinia or small pox
11/10/2004	EP1474448A1 Rrp sequences and knockout mice and uses thereof
11/10/2004	EP1474440A2 Coniosulphides and their derivatives, method for their production and use as medicaments
11/10/2004	EP1474438A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
11/10/2004	EP1474434A2 The eaat2 promoter and uses thereof
11/10/2004	EP1474167A2 Novel proteins in enteroaggregative esheriachia coli (eaec) useful for diagnosis and therapy of eaec infections
11/10/2004	EP1474156A2 Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors
11/10/2004	EP1474120A2 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
11/10/2004	EP1166112A4 Method for quantifying transforming growth factor-beta 1 and method for detecting cancer by using same
11/10/2004	EP0975742B1 Aminopeptidase derived from bacillus licheniformis and process for preparation of natural type proteins
11/10/2004	EP0760852B1 Immunosuppressant target proteins
11/10/2004	CN1545551A Human monoclonal antibody against hepatitis C virus E2 glycoprotein
11/10/2004	CN1544646A Bitterless soybean polypeptide and its production method
11/10/2004	CN1544641A Method for improving plant nutrition quality utilizing gene engineering technology
11/10/2004	CN1544636A Preparation and identification method for aldose reductase-like protein (ARL-1) monoclonal antibody
11/10/2004	CN1544632A Gene associated with plant salt resistance and drought resistance, encoded protein and application thereof
11/10/2004	CN1544629A Method for preparing recombinant goose interleukin-2 protein and its application
11/10/2004	CN1544628A Trichina TS88 gene, their protein products and uses
11/10/2004	CN1544625A Method for construction of bombyx mori virus fast gene expression system utilizing bacterium transposon

1 ... 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 ... 1125